Sullivan, Bruyette, Speros & Blaney’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$363K Hold
2,304
0.02% 219
2020
Q4
$381K Buy
2,304
+24
+1% +$3.9K 0.02% 195
2020
Q3
$377K Buy
2,280
+534
+31% +$82.1K 0.02% 176
2020
Q2
$239K Sell
1,746
-36
-2% -$4.7K 0.01% 211
2020
Q1
$210K Sell
1,782
-149
-8% -$19.6K 0.01% 200
2019
Q4
$256K Buy
1,931
+66
+4% +$8.2K 0.01% 215
2019
Q3
$232K Hold
1,865
0.01% 212
2019
Q2
$212K Buy
+1,865
New +$195K 0.01% 220

Other funds holding ZTS

Sullivan, Bruyette, Speros & Blaney's ZTS Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney held its Zoetis (ZTS) position steady in Q1 2021 at 2,304 shares worth $363K. The position accounts for 0.02% of the portfolio, ranked #219.

Sullivan, Bruyette, Speros & Blaney first reported a position in ZTS in Q2 2019 and has held it in 8 quarters since. The position peaked at $381K in Q4 2020. 1,415 funds tracked by Wall St. Rank hold ZTS as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 2,304 shares of Zoetis worth $363K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney left its Zoetis share count unchanged in Q1 2021.
  • Zoetis made up 0.02% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #219 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Zoetis in Q2 2019 and has held it in 8 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Zoetis position peaked at $381K in Q4 2020.
  • 1,415 funds tracked by Wall St. Rank held Zoetis as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.